
Sign up to save your podcasts
Or


Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.
By American Academy of Neurology4.7
285285 ratings
Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.

319 Listeners

504 Listeners

52 Listeners

3,379 Listeners

15 Listeners

1,141 Listeners

24 Listeners

194 Listeners

521 Listeners

135 Listeners

367 Listeners

190 Listeners

376 Listeners

321 Listeners

81 Listeners